
Trilotab Chewable Tablets for Dogs
Trilotab Chewable Tablets for Dogs
Cushing’s syndrome, also known as hyperadrenocorticism (HAC), is one of the most common endocrine diseases affecting dogs. It can cause a variety of symptoms, including lethargy, hair loss, muscle weakness, and increased thirst and urination.
Trilotab contains trilostane, a synthetic steroid analogue that works by blocking the production of cortisol, a hormone that is overproduced in dogs with Cushing's syndrome.
Trilotab is available in three different strengths (10mg, 30mg, and 60mg) and the tablets are easily divisible, allowing for precise dosing and tailored treatment plans for each individual dog.
The chewable tablets are flavoured with hydrolysed chicken, making them more palatable for dogs and easier to administer. With its convenient dosing and effectiveness in managing Cushing's syndrome, Trilotab can help improve the quality of life for dogs suffering from this condition.
Pharmaceutical form - Tablet. Off-white to light brown with brown spots, round and convex tablet with a cross-shaped break line on one side. Tablets can be divided into 2 or 4 equal parts.
Special precautions for safe use in animals - The tablets are flavoured. In order to avoid any accidental ingestion, store tablets out of reach of animals.
Special precautions to be taken by the person administering the veterinary medicinal product to animals - Accidental ingestion of the product can cause gastrointestinal effects, such as nausea and vomiting. Avoid hand to mouth contact. To avoid accidental ingestion, especially by a child, unused tablet parts should be placed back into the blister and carton and carefully kept away from children. Part used tablets should be used at the time of the next dose. In case of accidental ingestion, seek medical advice immediately and show the package leaflet or carton to the physician. Wash hands with soap and water after use.
Special precautions for storage - Do not store above 25°C. Any remaining portions of divided tablets should be returned to the opened blister and given at the next administration.